Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
national top stories
new york blog main
5
×
san diego blog main
san francisco blog main
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
fda
praluent
vc
alzheimer's
amgen
biogen
deals
donald trump
gene therapy
merck
novartis
pbm
regeneron pharmaceuticals
What
healthcare
5
×
bio
roundup
moves
new
america
american
based
becker
best
bigger
billions
biogen
cholesterol
continue
continues
convoluted
crash
deals
debate
democrats
dollars
dreams
drug
drugs
eaton
exits
expensive
faces
financial
foe
founders
funding
gene
head
headaches
health's
hint
holding
impact
Language
unset
Current search:
healthcare
×
" life sciences "
×
" new york blog main "
×
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
After 33 Exits in 5 Years, WI Seeks “More and Bigger” Startup Deals